Oncology

28 years of oncology expertise transforming promising ideas into breakthrough therapies

In-vitro cytotoxicity testing for anti-cancer drug development. Analyze the biological activity of your compound by itself or in combination with known anti-cancer drugs (see below).

2D Cancer Cells and Primary Cell Lines (2)-1

From Discovery to IND: Oncology Solutions

ChatGPT Image Feb 6, 2026, 03_55_50 PM-1

Biomarkers

ChatGPT Image Feb 6, 2026, 03_55_50 PM-2-1

Bioassays

ChatGPT Image Feb 6, 2026, 03_55_50 PM-3-1

Cytokines

ChatGPT Image Feb 6, 2026, 03_55_50 PM-4

mAbs

ChatGPT Image Feb 6, 2026, 03_55_50 PM-Feb-06-2026-09-06-47-8201-PM

Bioanalysis

ChatGPT Image Feb 6, 2026, 03_55_50 PM-Feb-06-2026-09-07-33-6836-PM

Cell & Gene Therapy

ChatGPT Image Feb 6, 2026, 03_55_50 PM-Feb-06-2026-09-08-15-7797-PM

Small Molecule

ChatGPT Image Feb 6, 2026, 03_55_50 PM-Feb-06-2026-09-08-50-3909-PM

Antibody Development

ChatGPT Image Feb 6, 2026, 03_55_50 PM-Feb-06-2026-09-10-52-1925-PM

Biosimilars

ChatGPT Image Feb 6, 2026, 03_55_50 PM-Feb-06-2026-09-10-14-1794-PM

Molecular Diagnostics

500 +

Mammalian Cell Lines

380

Human Cancer Cell Lines

50 +

Anti-Cancer Drugs

7

NCEs
Screenshot 2026-02-03 at 10.15.16 AM

TEST FASTER. COMPARE EASIER. DISCOVER MORE. Compare, Combine and Validate Against Proven Cancer Drugs

Access a curated panel of approved and investigational oncology drugs for immediate comparison and combination studies, alongside testing across 380 human cancer cell lines. 

Cancer Drugs Available for Research Purposes

Peptide Therapeutics Development

Lead Drug Optimization Services

Antibody-Drug Conjugates (ADCs) Analytical Characterization Drug-to-antibody ratio (DAR) by HIC-HPLC Functional Potency Cell-killing mechanisms Proliferation inhibition (MTTXTT), apoptosis (caspas (1)

Cyclization

Antibody-Drug Conjugates (ADCs) Analytical Characterization Drug-to-antibody ratio (DAR) by HIC-HPLC Functional Potency Cell-killing mechanisms Proliferation inhibition (MTTXTT), apoptosis (caspas (2)

Biotinylation

Antibody-Drug Conjugates (ADCs) Analytical Characterization Drug-to-antibody ratio (DAR) by HIC-HPLC Functional Potency Cell-killing mechanisms Proliferation inhibition (MTTXTT), apoptosis (caspas (3)

Phosphorylation

Antibody-Drug Conjugates (ADCs) Analytical Characterization Drug-to-antibody ratio (DAR) by HIC-HPLC Functional Potency Cell-killing mechanisms Proliferation inhibition (MTTXTT), apoptosis (caspas (4)

Glycosylation

Antibody-Drug Conjugates (ADCs) Analytical Characterization Drug-to-antibody ratio (DAR) by HIC-HPLC Functional Potency Cell-killing mechanisms Proliferation inhibition (MTTXTT), apoptosis (caspas (5)

Binding of Specific Small MW Toxic-Drug

Antibody-Drug Conjugates (ADCs) Analytical Characterization Drug-to-antibody ratio (DAR) by HIC-HPLC Functional Potency Cell-killing mechanisms Proliferation inhibition (MTTXTT), apoptosis (caspas (6)

Non-Radioactive Cytotoxicity Assays

Multi-Tox Glo Multiplex Assay & ApoGlow

High Impact Anti-Cancer Drug Screening

SBH Sciences is actively collaborating with Karyopharm Therapeutics on its anti-cancer development program. We have used over 200 cancer cell lines in this collaboration and are continuing to screen for promising anti-cancer drugs. SBH Sciences and Karyopharm Therapeutics have presented 10 scientific abstracts together.